Among Android phones connecting to Starlink, a third are on AT&T. Only 2.2% are on Verizon, likely because they already have ...

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to ...

A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...

Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

“It’s possible that the mice weren’t seeing them,” admits Shin, “because the technique has involved a relatively small number ...